These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1219 related items for PubMed ID: 26803418

  • 21. Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry®.
    Wang TY, Grines C, Ortega R, Dai D, Jacobs AK, Skelding KA, Mauri L, Mehran R.
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):663-8. PubMed ID: 26255880
    [Abstract] [Full Text] [Related]

  • 22. Temporal Trends, Complications, and Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Sawant AC, Josey K, Plomondon ME, Maddox TM, Bhardwaj A, Singh V, Rajagopalan B, Said Z, Bhatt DL, Corbelli J.
    JACC Cardiovasc Interv; 2017 Jul 10; 10(13):1295-1303. PubMed ID: 28683935
    [Abstract] [Full Text] [Related]

  • 23. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B, Abdel-Wahab M, Robinson DR, Richardt G.
    Med Klin Intensivmed Notfmed; 2016 Nov 10; 111(8):715-722. PubMed ID: 26596273
    [Abstract] [Full Text] [Related]

  • 24. Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005 to 2017: A nationwide cohort study.
    Lauridsen MD, Rørth R, Lindholm MG, Kjaergaard J, Schmidt M, Møller JE, Hassager C, Torp-Pedersen C, Gislason G, Køber L, Fosbøl EL.
    Am Heart J; 2020 Nov 10; 229():127-137. PubMed ID: 32861678
    [Abstract] [Full Text] [Related]

  • 25. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.
    Vora AN, Peterson ED, McCoy LA, Garratt KN, Kutcher MA, Marso SP, Roe MT, Messenger JC, Rao SV.
    JACC Cardiovasc Interv; 2016 Apr 25; 9(8):771-779. PubMed ID: 27101904
    [Abstract] [Full Text] [Related]

  • 26. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
    Iyanoye A, Moreyra AE, Swerdel JN, Gandhi SK, Cabrera J, Cosgrove NM, Kostis JB, MIDAS 23 Study Group.
    Catheter Cardiovasc Interv; 2015 Aug 25; 86(2):221-8. PubMed ID: 25645156
    [Abstract] [Full Text] [Related]

  • 27. Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program.
    Kataruka A, Maynard CC, Kearney KE, Mahmoud A, Bell S, Doll JA, McCabe JM, Bryson C, Gurm HS, Jneid H, Virani SS, Lehr E, Ring ME, Hira RS.
    J Am Heart Assoc; 2020 Jun 02; 9(11):e015317. PubMed ID: 32456522
    [Abstract] [Full Text] [Related]

  • 28. Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity.
    Shah RU, Henry TD, Rutten-Ramos S, Garberich RF, Tighiouart M, Bairey Merz CN.
    JACC Cardiovasc Interv; 2015 Jan 02; 8(1 Pt B):139-146. PubMed ID: 25616918
    [Abstract] [Full Text] [Related]

  • 29. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z, Baber U, Claessen BE, Farhan S, Chandrasekhar J, Li SX, Sartori S, Kini AS, Rao SV, Weiss S, Henry TD, Vogel B, Sorrentino S, Faggioni M, Kapadia S, Muhlestein B, Strauss C, Toma C, DeFranco A, Effron MB, Keller S, Baker BA, Pocock S, Dangas G, Mehran R.
    Catheter Cardiovasc Interv; 2019 Feb 15; 93(3):E112-E119. PubMed ID: 30351514
    [Abstract] [Full Text] [Related]

  • 30. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011.
    Sugiyama T, Hasegawa K, Kobayashi Y, Takahashi O, Fukui T, Tsugawa Y.
    J Am Heart Assoc; 2015 Mar 23; 4(3):e001445. PubMed ID: 25801759
    [Abstract] [Full Text] [Related]

  • 31. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry.
    Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, Erne P, Rickli H, Pilgrim T, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators.
    Circ Cardiovasc Interv; 2019 Apr 23; 12(4):e007293. PubMed ID: 30943781
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
    Mehta RH, Ou FS, Peterson ED, Shaw RE, Hillegass WB, Rumsfeld JS, Roe MT, American College of Cardiology-National Cardiovascular Database Registry Investigators.
    JACC Cardiovasc Interv; 2009 Jan 23; 2(1):56-64. PubMed ID: 19463399
    [Abstract] [Full Text] [Related]

  • 33. The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry.
    Gruberg L, Hellkamp AS, Thomas LE, de Lemos JA, Scirica BM, Hilliard A, Enriquez JR, Mohsen A, Wang TY.
    JACC Cardiovasc Interv; 2015 Dec 28; 8(15):1954-1962. PubMed ID: 26738665
    [Abstract] [Full Text] [Related]

  • 34. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
    Fuernau G, Fengler K, Desch S, Eitel I, Neumann FJ, Olbrich HG, de Waha A, de Waha S, Richardt G, Hennersdorf M, Empen K, Hambrecht R, Jung C, Böhm M, Pöss J, Strasser RH, Schneider S, Ouarrak T, Schuler G, Werdan K, Zeymer U, Thiele H.
    Clin Res Cardiol; 2016 Dec 28; 105(12):1030-1041. PubMed ID: 27378612
    [Abstract] [Full Text] [Related]

  • 35. Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry.
    Baber U, Giustino G, Wang T, Grines C, McCoy LA, Saha-Chaudhuri P, Best P, Skelding KA, Ortega R, Chieffo A, Mehilli J, Tcheng J, Mehran R.
    Coron Artery Dis; 2016 Sep 28; 27(6):442-8. PubMed ID: 27100661
    [Abstract] [Full Text] [Related]

  • 36. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.
    Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A.
    Thromb Haemost; 2014 Dec 28; 112(6):1190-7. PubMed ID: 25183544
    [Abstract] [Full Text] [Related]

  • 37. Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data Registry CathPCI Registry.
    Beohar N, Kaltenbach LA, Wojdyla D, Pineda AM, Rao SV, Stone GW, Leon MB, Sanghvi KA, Moses JW, Kirtane AJ.
    Circ Cardiovasc Interv; 2020 Feb 28; 13(2):e008239. PubMed ID: 31973557
    [Abstract] [Full Text] [Related]

  • 38. Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry.
    Zeymer U, Hochadel M, Hauptmann KE, Wiegand K, Schuhmacher B, Brachmann J, Gitt A, Zahn R.
    Clin Res Cardiol; 2013 Mar 28; 102(3):223-7. PubMed ID: 23179136
    [Abstract] [Full Text] [Related]

  • 39. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, Hochadel M, Marco J, Gitt A.
    EuroIntervention; 2011 Aug 28; 7(4):437-41. PubMed ID: 21764661
    [Abstract] [Full Text] [Related]

  • 40. Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention.
    Curtis JP, Geary LL, Wang Y, Chen J, Drye EE, Grosso LM, Spertus JA, Rumsfeld JS, Weintraub WS, Masoudi FA, Brindis RG, Krumholz HM.
    Circ Cardiovasc Qual Outcomes; 2012 Sep 01; 5(5):628-37. PubMed ID: 22949491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.